Cargando…

Histone deacetylase inhibitors containing a benzamide functional group and a pyridyl cap are preferentially effective human immunodeficiency virus-1 latency-reversing agents in primary resting CD4(+) T cells

Antiretroviral therapy (ART) can control human immunodeficiency virus-1 (HIV-1) replication in infected individuals. Unfortunately, patients remain persistently infected owing to the establishment of latent infection requiring that ART be maintained indefinitely. One strategy being pursued involves...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kobayashi, Yoshifumi, Gélinas, Céline, Dougherty, Joseph P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Microbiology Society 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5657027/ https://www.ncbi.nlm.nih.gov/pubmed/28113052 http://dx.doi.org/10.1099/jgv.0.000716

Ejemplares similares

Novel Histone Deacetylase Inhibitors and HIV-1 Latency-Reversing Agents Identified by Large-Scale Virtual Screening
por: Divsalar, Donya Naz, et al.
Publicado: (2020)

Proteasome inhibitors act as bifunctional antagonists of human immunodeficiency virus type 1 latency and replication
por: Miller, Leia K, et al.
Publicado: (2013)

N-(1,10-Phenanthrolin-5-yl)-4-(2-pyridyl)benzamide monohydrate
por: Kobayashi, Masayuki, et al.
Publicado: (2008)

2,3-Difluoro-N-(2-pyridyl)benzamide
por: Gallagher, John F., et al.
Publicado: (2008)

Discovery of potent histone deacetylase inhibitors with modified phenanthridine caps
por: Fan, Wenli, et al.
Publicado: (2021)

In Vitro Assessment of the Genotoxic Hazard of Novel Hydroxamic Acid- and Benzamide-Type Histone Deacetylase Inhibitors (HDACi)
por: Friedrich, Annabelle, et al.
Publicado: (2020)

Combinations of Histone Deacetylase Inhibitors with Distinct Latency Reversing Agents Variably Affect HIV Reactivation and Susceptibility to NK Cell-Mediated Killing of T Cells That Exit Viral Latency
por: Covino, Daniela A., et al.
Publicado: (2021)

2-Ferrocenyl-N-(6-methyl-2-pyridyl)benzamide
por: Gallagher, John F., et al.
Publicado: (2010)

2-Iodo-N-(6-methyl-2-pyridyl)benzamide
por: Fun, Hoong-Kun, et al.
Publicado: (2008)

FKBP3 Induces Human Immunodeficiency Virus Type 1 Latency by Recruiting Histone Deacetylase 1/2 to the Viral Long Terminal Repeat
por: Yang, Xinyi, et al.
Publicado: (2021)

HIV anti-latency treatment mediated by macromolecular prodrugs of histone deacetylase inhibitor, panobinostat
por: Zuwala, Kaja, et al.
Publicado: (2016)

Discovery of N-(2-Aminophenyl)-4-(bis(2-chloroethyl)amino)Benzamide as a Potent Histone Deacetylase Inhibitor
por: Zhang, Lihui, et al.
Publicado: (2019)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020)

Reversing resistance to antiandrogens with a histone deacetylase inhibitor
por: Ferrari, Anna C.
Publicado: (2018)

Reversible histone deacetylase activity catalyzes lysine acylation
por: Tsusaka, Takeshi, et al.
Publicado: (2023)

2-Methyl-N-[(3-methyl-2-pyridyl)carbamothioyl]benzamide
por: Yamin, B. M., et al.
Publicado: (2008)

Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors
por: Kalin, Jay H., et al.
Publicado: (2018)

3-Fluoro-N-(3-fluorobenzoyl)-N-(2-pyridyl)benzamide
por: Gallagher, John F., et al.
Publicado: (2008)

2-Fluoro-N-(2-fluorobenzoyl)-N-(2-pyridyl)benzamide
por: Gallagher, John F., et al.
Publicado: (2009)

Ongoing Clinical Trials of Human Immunodeficiency Virus Latency-Reversing and Immunomodulatory Agents
por: Delagrèverie, Héloïse M., et al.
Publicado: (2016)

Target Design of Novel Histone Deacetylase 6 Selective Inhibitors with 2-Mercaptoquinazolinone as the Cap Moiety
por: Bui, Hue Thi Buu, et al.
Publicado: (2022)

Feline immunodeficiency virus latency
por: McDonnel, Samantha J, et al.
Publicado: (2013)

Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors
por: Lapierre, Marion, et al.
Publicado: (2016)

Beyond Histone and Deacetylase: An Overview of Cytoplasmic Histone Deacetylases and Their Nonhistone Substrates
por: Yao, Ya-Li, et al.
Publicado: (2011)

2-Ferrocenyl-N-(2-ferrocenylbenzoyl)-N-(4-methyl-2-pyridyl)benzamide
por: Gallagher, John F., et al.
Publicado: (2009)

Mesomorphic Behavior in Silver(I) N-(4-Pyridyl) Benzamide with Aromatic π–π Stacking Counterions
por: Torres, Issac, et al.
Publicado: (2018)

Future approaches to clearing the latent human immunodeficiency virus reservoir: Beyond latency reversal
por: Hayes, Alexander M.L.
Publicado: (2020)

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
por: Sanaei, Masumeh, et al.
Publicado: (2019)

4-Chloro-N-[N-(6-methyl-2-pyridyl)carbamothioyl]benzamide
por: Binzet, Gün, et al.
Publicado: (2008)

Role of histone deacetylase 1 in distant metastasis of pancreatic ductal cancer
por: Shinke, Go, et al.
Publicado: (2018)

Chidamide combined with paclitaxel effectively reverses the expression of histone deacetylase in lung cancer
por: Zhang, Na, et al.
Publicado: (2020)

Human endogenous retrovirus (HERV) expression is not induced by treatment with the histone deacetylase (HDAC) inhibitors in cellular models of HIV-1 latency
por: Hurst, Tara, et al.
Publicado: (2016)

The Rice NAD(+)-Dependent Histone Deacetylase OsSRT1 Targets Preferentially to Stress- and Metabolism-Related Genes and Transposable Elements
por: Zhong, Xiaochao, et al.
Publicado: (2013)

Borinostats: solid-phase synthesis of carborane-capped histone deacetylase inhibitors with a tailor-made selectivity profile
por: Selg, Christoph, et al.
Publicado: (2021)

Polycomb- and REST-associated histone deacetylases are independent pathways toward a mature neuronal phenotype
por: McGann, James C, et al.
Publicado: (2014)

Development and Biological Evaluation of the First Highly Potent and Specific Benzamide-Based Radiotracer [(18)F]BA3 for Imaging of Histone Deacetylases 1 and 2 in Brain
por: Clauß, Oliver, et al.
Publicado: (2022)

Chemical Phylogenetics of Histone Deacetylases
por: Bradner, James E., et al.
Publicado: (2010)

Histone deacetylases in viral infections
por: Herbein, Georges, et al.
Publicado: (2010)

Butyrate Histone Deacetylase Inhibitors
por: Steliou, Kosta, et al.
Publicado: (2012)

Histone deacetylase signaling in cardioprotection
por: Lehmann, Lorenz H., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_uk2gois73kebv4hn4ue7rlheqe